The p110δ isoform of PI 3-kinase negatively controls RhoA and PTEN

117Citations
Citations of this article
101Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Inactivation of PI 3-kinase (PI3K) signalling is critical for tumour suppression by PTEN. This is thought to be a unidirectional relationship in which PTEN degrades the lipids produced by PI3K, thus controlling cell proliferation, survival and migration. We now show that this relationship is in fact bidirectional, whereby PI3K reciprocally controls PTEN. We report that the p110δ PI3K negatively regulates PTEN, through a pathway involving inhibition of RhoA. Inactivation of p110δ in macrophages led to reduced Akt and Rac1 activation, but paradoxically to increased RhoA and PTEN activity. Partial inactivation of p190RhoGAP and a reduced binding of cytoplasmic RhoA to the cyclin-dependent kinase inhibitor p27 both contributed to the increased RhoA-GTP levels upon p110δ inactivation. Pharmacological inhibition of ROCK, a downstream effector kinase of RhoA, restored all signalling and functional defects of p110δ inactivation, including Akt phosphorylation, chemotaxis and proliferation. This work identifies the RhoA/ROCK pathway as a major target of p110δ-mediated PI3K signalling, and establishes for the first time that PI3K controls itself, via a feedback loop involving PTEN. © 2007 European Molecular Biology Organization | All Rights Reserved.

Cite

CITATION STYLE

APA

Papakonstanti, E. A., Ridley, A. J., & Vanhaesebroeck, B. (2007). The p110δ isoform of PI 3-kinase negatively controls RhoA and PTEN. EMBO Journal, 26(13), 3050–3061. https://doi.org/10.1038/sj.emboj.7601763

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free